3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.

Bioorg Med Chem Lett

Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA 02139, USA.

Published: March 2010

A series of 3-aryl-4-(arylhydrazono)-1H-pyrazol-5-one inhibitors of GSK3beta was developed from a low molecular weight, highly ligand efficient screening hit 1. Hit-to-lead optimization led to a number of highly potent inhibitors, while maintaining the high ligand efficiency of the screening hit.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.01.072DOI Listing

Publication Analysis

Top Keywords

highly ligand
8
ligand efficient
8
potent inhibitors
8
inhibitors gsk3beta
8
screening hit
8
3-aryl-4-arylhydrazono-1h-pyrazol-5-ones highly
4
efficient potent
4
gsk3beta series
4
series 3-aryl-4-arylhydrazono-1h-pyrazol-5-one
4
3-aryl-4-arylhydrazono-1h-pyrazol-5-one inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!